Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Frequency Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2020 4 Arnold Wendy S (Chief People Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 130,000 options @ $25.05, valued at $3.3M
02/14/2020 4 Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 18,000 options @ $25.05, valued at $450.9k
02/11/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
02/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2020 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : January 13, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 unde..."
01/02/2020 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Exercised 36,590 options @ $0.61, valued at $22.3k
Exercised 20,787 options @ $0.61, valued at $12.7k
12/05/2019 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 96,361 options @ $3.37, valued at $324.7k
12/05/2019 4 COHEN MARC A (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 20,778 options @ $3.37, valued at $70k
12/05/2019 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 64,241 options @ $3.37, valued at $216.5k
12/05/2019 4 LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 23,555 options @ $3.37, valued at $79.4k
11/18/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/18/2019 8-K Quarterly results
11/14/2019 8-K Quarterly results
10/11/2019 SC 13G PERCEPTIVE ADVISORS LLC reports a 10% stake in Frequency Therapeutics, Inc.
10/09/2019 4 Alexandria Venture Investments, LLC (10% Owner) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Converted 956,175 shares @ $0
Converted 4,161,974 convertible preferred @ $0
Converted 2,278,345 convertible preferred @ $0
10/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/08/2019 4 Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Converted 4,032 shares @ $0
Bought 107 shares @ $14, valued at $1.5k
Converted 27,160 preferred shares @ $0
10/07/2019 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Converted 10,563 shares @ $0
Converted 43,989 preferred shares @ $0
Converted 27,161 preferred shares @ $0
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Converted 6,708 shares @ $0
Converted 45,182 preferred shares @ $0
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 8-K Quarterly results
10/07/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/04/2019 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
10/03/2019 EFFECT Form EFFECT - Notice of Effectiveness:
10/02/2019 4 McLean William J. (10% Owner) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 111,350 options @ $14, valued at $1.6M
10/02/2019 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 96,361 options to buy @ $3.37, valued at $324.7k
Granted 444,371 options to buy @ $3.37, valued at $1.5M
Granted 714,413 options @ $14, valued at $10M
10/02/2019 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 64,241 options to buy @ $3.37, valued at $216.5k
Granted 360,606 options to buy @ $3.37, valued at $1.2M
Granted 146,826 options @ $14, valued at $2.1M
10/02/2019 4 Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 33,305 options to buy @ $3.37, valued at $112.2k
Granted 17,816 options @ $14, valued at $249.4k
10/02/2019 4 LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 23,555 options to buy @ $3.37, valued at $79.4k
Granted 101,930 options to buy @ $3.37, valued at $343.5k
Granted 178,937 options @ $14, valued at $2.5M
10/02/2019 3 Alexandria Venture Investments, LLC (10% Owner) has filed a Form 3 on Frequency Therapeutics, Inc.
10/02/2019 3 MARCUS JOEL S (10% Owner) has filed a Form 3 on Frequency Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy